EMPACOZA TRIO XR 25/5/1000MG 30TAB 6224002652010

Short Description:
EMPACOZA TRIO XR 25/5/1000 mg is a triple-combination extended-release antidiabetic tablet containing empagliflozin, linagliptin, and metformin to improve glycemic control in adults with type 2 diabetes. It offers complementary mechanisms of action to lower fasting and postprandial blood glucose when diet, exercise, and previous therapy are insufficient, under medical supervision.